Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Know Your Unknown Unknowns

David S. Pisetsky, MD, PhD  |  Issue: October 2007  |  October 1, 2007

Our surgical colleagues, however, demurred on this course of action. Too many steroids, they said, and far too soon. In a conference outside the patient’s room, the surgeons said that a new graft in the aorta needs time to settle in, a process that should be unperturbed by steroids. Also, there were wounds to close and, the sharp-eyed surgical chief resident said, casting a baleful eye on our group, “You know what steroids do to wounds.” Of course we knew. They make them break and leak. While vasculitis may be bad, a dehiscence could be worse was the surgeon’s clear message.

Two Opinions and No Right Answer

The fellow involved in this case is very diligent. She scoured the literature to find evidence to resolve this dilemma and put real numbers and probabilities on the concerns of both the rheumatologists and thoracic surgeons. Evidence is wonderful but it often seems like the pot of gold at the end of the rainbow – something you search for but never find.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Suffice it to say that no study the fellow perused provided the answer. There were no known knowns in this field: no decisive information on the course of GCA presenting in the aorta, the chance blindness would occur if left untreated, or the chance steroids would impair wound healing. The probabilities of outcomes were – at best – a guess. No better than tossing a dart at a map to determine where to go.

I could list the known unknowns and unknown unknowns in this case and, as we discovered in our research and discussions, there were even unknown knowns. Unknown knowns are things that we should have known but didn’t. The unknowns, however, were paramount and can be reduced to a simple question: How likely were these events?

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

To our consulting service, the job was twofold: Convey the urgency to treat vasculitis and reassure the surgeon that a short burst of steroids would not disturb the healing of the graft and make the surgeon’s handiwork an exercise in futility.

I will not reveal the outcome of the discussion that ensued because – on both sides – it was ultimately based on personal assessments of known unknowns and unknown unknowns. To the rheumatologist, the consequences of untreated vasculits are dire: blindness, stroke, and infarction. To the surgeon, the consequences of poor wound healing are equally bad, with an aortic graft blowing out at the top of the list.

Page: 1 2 3 | Single Page
Share: 

Filed under:OpinionRheuminationsSpeak Out RheumVasculitis Tagged with:Cardiovascular diseasecase reportDiagnostic CriteriaGiant Cell ArteritisGlucocorticoidsPathogenesisSteroidsTreatment

Related Articles

    Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection

    March 1, 2013

    Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously

    Updates on Giant Cell Arteritis

    March 19, 2018

    SAN DIEGO—Recent research tells us more about giant cell arteritis (GCA) to help rheumatologists more accurately diagnose and effectively treat patients with this type of vasculitis. On Nov. 6 at the ACR/ARHP Annual Meeting, three experts explored the latest findings on GCA pathogenesis, diagnostic approaches, imaging modalities and growing treatment options. GCA: What’s Really Happening?…

    Giant Cell Arteritis Challenging to Diagnose, Manage

    March 1, 2015

    Common form of primary vasculitis difficult to identify, treat, but latest research suggests potential new therapeutic targets

    Case Report: Giant Cell Arteritis-Related Stroke

    September 10, 2023

    Thromboembolic events are major contributors to the morbidity and mortality of patients with giant cell arteritis (GCA), but little is known about how GCA may increase the risk of ischemic strokes. GCA-related stroke is described as an ischemic cerebral infarct occurring within three to four weeks of GCA diagnosis and treatment. It occurs in 3–7%…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences